[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"sacroiliac-joint-disruption\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:sacroiliac-joint-disruption":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":31,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100636427","posterior-inferior-intra-articular-cortical-piercing-titanium-implant-for-sacroiliac-joint-fusion-evaluation-of-safety-and-effectiveness-outcomes-100636427",false,"NCT07565545","Posterior-Inferior Intra-articular Cortical Piercing Titanium Implant for Sacroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes","Posterior-Inferior Intra-articular Cortical PiERcing Titanium Implant for SaCroiliac Joint Fusion: Evaluation of Safety and Effectiveness Outcomes","PIERCE","Inclusion Criteria:\n\n1. Age \\> 21 years.\n2. Patient has chronic lower back pain (≥6 months) refractory to non-surgical care.\n3. Diagnosis of sacroiliac joint dysfunction (degenerative sacroiliitis or SIJ disruption) and scheduled to be treated with INTRA Ti.\n4. Patient has SIJ pain of at least 5 on a 0-10 numeric rating scale (NRS) prior to procedure.\n5. Participant has signed study-specific informed consent form.\n\nExclusion Criteria:\n\n1. ASA score 4 or 5.\n2. Severe back pain due to other causes, such as lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, and lumbar vertebral body fracture.\n3. Other known sacroiliac pathology such as: inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA-associated spondyloarthropathy), tumor, infection, acute fracture.\n4. Current diagnosis of cluneal neuralgia.\n5. Previous SIJ implant placement, including allograft, on the treated (index) side.\n6. Anatomic anomalies\u002Fdefects that would preclude safe and\u002For biomechanically acceptable device placement.\n7. History of recent (\\\u003C1 year) major trauma to pelvis.\n8. Previously diagnosed or suspected severe osteoporosis (defined as prior T-score \\\u003C -2.5 or history of osteoporotic fracture).\n9. Chronic rheumatologic condition (e.g., rheumatoid arthritis).\n10. Current diagnosis of fibromyalgia.\n11. Known allergy to titanium or titanium alloys.\n12. Current local or systemic infection that raises the risk of surgery.\n13. Patient currently receiving or seeking worker's compensation, disability remuneration, and\u002For involved in injury litigation.\n14. Currently pregnant or planning pregnancy in the next 2 years (self-reported).\n15. Patient is a prisoner or a ward of the state.\n16. Known or suspected active drug or alcohol abuse, including opioids\n17. Diagnosed psychiatric disease (e.g., schizophrenia, major depression, personality disorders) that could interfere with study participation.","ALL","21 Years",{"count":20,"type":21},120,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to evaluate outcomes in patients treated with iFuse INTRA Ti for chronic SI joint pain.",[25,26,27,28,29,30],"Sacro Iliac Joint Pain","Sacro-iliac Joints","Sacroiliac Disorder","Sacroiliac Joint Dysfunction","Sacroiliac Joint Disruption","Degenerative Sacroiliitis",[32,33,34],"sacroiliac fusion","SI-BONE","INTRA Ti","NOT_YET_RECRUITING","2026-06-17",{"date":38,"type":39},"2026-06-22","ACTUAL",{"date":41,"type":21},"2026-09",{"date":43,"type":21},"2029-09",{"name":45,"class":46},"SI-BONE, Inc.","INDUSTRY",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":52,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":17,"minAge":54,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":56,"conditions":57,"keywords":62,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":4},"100633731","real-world-evidence-of-si-bones-ifuse-torq-tnt-advancing-treatment-of-pelvic-ring-fractures-100633731","NCT07530497","Real World Evidence of SI-BONE's iFuse TORQ TNT Advancing Treatment of Pelvic Ring Fractures","REBAR","Inclusion Criteria:\n\n1. ≥ 60 years of age at screening\n2. Pelvic pain correlating with fracture location that began EITHER within 6 weeks of a known low-energy traumatic event, OR pelvic insufficiency fracture with pain that is limiting mobility\n3. Diagnostic imaging (X-ray and CT) showing fracture of the pelvis that correlates with pain location\n4. Patient is scheduled for pelvic fixation using at least one iFuse TORQ TNT\n5. Patient and\u002For patient's legally authorized representative (LAR) understands and is willing and able to provide written informed consent\n6. Patient agrees to comply with study schedule of assessments\n7. Patient and\u002For patient's proxy can complete study-related surveys\n8. Patient was able to ambulate prior to index fracture\n\nExclusion Criteria:\n\n1. Any known anatomic issues that could prevent placement of iFuse TORQ TNT\n2. Implants already in the pelvis (e.g. lumbopelvic fixation) that could interfere with placement of the study device(s)\n3. Patient requires lumbosacral pelvic fixation as part of index procedure\n4. Prominent neurologic or uncontrolled psychiatric condition that would interfere with study participation or regaining of physical function related to pelvic fracture and is unable to provide a health care proxy to complete study assessments.\n5. Estimated lifespan \\\u003C 12 months\n6. Presence of tumor, lytic lesion, infection, or soft tissues that precludes safe internal fixation\n7. Not candidate for surgery due to underlying medical illness\n8. Social situation that makes 12-month follow-up unlikely\n9. History of recent (within 1 year) non-index pelvic fracture with non-union\n10. Other clinically active fragility fracture of spine, hip or arms\u002Flegs that could impair recovery from sacral fracture\n11. Known allergy to titanium or titanium alloys\n12. Known or suspected active drug or alcohol abuse, including opioids\n13. Patient is a prisoner or ward of the state\n14. Patient is already participating in an investigational clinical trial that may interfere with implant placement or study follow-up","60 Years",{"count":20,"type":21},"The purpose of this study is to evaluate outcomes in patients treated with iFuse TORQ TNT for pelvic fragility fractures.",[58,59,60,61,29,28],"Fracture; Pelvic","Insufficiency Fractures","Fragility Fracture","Sacroiliac; Fusion",[60,63,64,65],"pelvic fracture","Osteoporotic pelvic fracture","Fragility Fracture of the pelvis","2026-04-15",{"date":68,"type":39},"2026-04-20",{"date":70,"type":21},"2026-08",{"date":72,"type":21},"2028-08",{"name":45,"class":46}]